National comparative audit of patient information and consent for transfusion 2014: comparison of practice between clinical specialities
Excellent outcome for adults and older adolsecents following reduced intensity allogeneic haematopoietic stem cell transplantation for inherited primary immune deficiencies (PID)
Haemostatic changes, transfusion management and clinical outcomes of obstetric massive transfusion cases in the UK
Role of platelet coordinator in stewardship of platelet transfusion
Why is transfusion-associated circulatory overload (TACO) under-reported?
Challenging transfusion practice: significant reduction in red cell transfusions in medical patients through behavioural interventions
Emergency O negative red cells for women - defining the age of cut off for ‘child bearing potential’
Targeted next-generation sequencing reveals mutational complexity of familial platelet disorder with predisposition to acute myeloid leukaemia
The autophagy related protein ATG7 regulates differentiation and energy metabolism of CML cells
Pacritinib suppresses leukaemic outgrowth from stroma-adherent primary AML cells harbouring FLT3-ITD
Treatment of essential thrombocythaemia in Europe: an observational study of 3649 high-risk patients in EXELS
Immunological profile of patients after HSCT using the FCC conditioning regimen for treatment of severe aplastic anemia indicates potential basis for tolerance with mixed T-cell chimerism and extremely low incidence of GvHD
Donor lymphocyte infusion - a retrospective single centre audit
The observed incidence of cardiovascular ischemic events in dasatinib-treated patients in clinical trials compared with the expected incidence based on general external populations
A single-centre experience of treating adult patients with Langerhans’ cell histiocytosis and Erdheim Chester disease: sustained response to oral methotrexate in frontline and relapsed disease
Effects of rivaroxaban on routine tests of haemostasis as determined with a full range of reagents: results of a UK NEQAS exercise
Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome
Idarucizumab, a specific antidote for dabigatran: immediate, complete and sustained reversal of dabigatran induced anticoagulation in elderly and renally impaired subjects
Whole genome sequencing and inherited diseases of the blood stem cell and its progeny
Oral anticoagulant agent-associated bleeding events reporting system (ORANGE) study
The FVIII:C to VWF:Ag ratio in patients with von Willebrand disease type I may indicate co-inheritance of F8 or VWF 2N variants
ThromboGenomics: next generation sequencing to diagnose inherited bleeding, thrombotic and platelet disorders
Iron status in paediatric acute lymphoblastic leukaemia
Quantitative PCR using patient specific primers detects occult central nervous system involvement in more than one-third of children with acute lymphoblastic leukaemia
Central venous line placement prior to induction therapy in children with acute lymphoblastic leukaemia does not increase the risk of line-related thrombosis
The presence of non-tumour T and B lymphocytes in diagnostic bone marrow is associated with improved overall survival in childhood common acute lymphoblastic leukaemia
SPIRIT 2: an NCRI randomised study comparing dasatinib with imatinib in patients with newly diagnosed chronic myeloid leukaemia - 2 year follow up
Haemoglobinopathy survey - a picture of transfusion for sickle cell disease and thalassaemia in 11 London hospitals
In-vivo studies of trafficking in chronic lymphocytic leukaemia provide definitive evidence of re-entry into the lymph-node compartment and suggest the existence of a quiescent sub-clone
APL of all risk groups is highly curable with a chemo-free combination of attenuated arsenic trioxide and ATRA
Discovery of novel genes underlying inherited bleeding and platelet disorders by genome sequencing
Childhood pre-B acute lymphoblastic leukaemia cells capable of central nervous system engraftment are common, heterogeneous and transit the blood-cerebrospinal fluid barrier
Leukaemia-associated somatic mutations drive distinct patterns of age-related clonal haemopoiesis
Second interim analysis of a phase 3 study of idelalisib plus rituximab (R) for relapsed chronic lymphocytic leukaemia (CLL): efficacy analysis in patient subpopulations with Del(17p) and other adverse prognostic factors
Updated efficacy including subgroup analyses and safety in the phase 3 RESONATETM trial of ibrutinib versus ofatumumab in previously treated chronic lymphocytic leukaemia/small lymphocytic lymphoma
Interim results from ASPIRE, a randomized, open-label, multicenter phase 3 study evaluating carfilzomib, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in patients with relapsed multiple myeloma
Dual mTOR inhibition is an effective therapeutic approach for reducing tumour load in chronic lymphocytic leukaemia
Mature follow up from a phase 2 study of PI3K-delta inhibitor idelalisib in patients with double (rituximab and alkylating agent)- refractory indolent B-cell non-Hodgkin lymphoma (iNHL)
Phase 2a study of copanlisib, a novel phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with relapsed/refractory, idolent or aggressive lymphoma
Nocturnal desaturation and proteinuria in children with sickle cell anaemia
R2 MRI quantification of hepatic iron: an additional tool in the management of patients with HFE gene mutations
Review of regular automated red cell exchange transfusions and the associated risk of iron overload in patients with sickle cell disease
Transcranial Doppler screening and residual stroke rate in UK children with sickle cell disease: data from the East London and Essex clinical haemoglobinopathy network
Identifying and characterizing spontaneous cerebrovascular disease in a murine model of human sickle cell disease
A prospective ‘live’ audit of a community-based electronic haematology advice service for GPs
Epidemiological research on Hodgkin lymphoma in Morocco
A survey of regional anaesthetic practice in immune and gestational thrombocytopenia in pregnancy
Assessing the care experiences of people living with sickle cell disease to inform the development of a patient reported experience measure (PREM)
Audit of the use of chest X-rays in the management of adult neutropenic sepsis at King's College Hospital, London
Introduction of a regional apheresis roadmap: experience from the North West of England and North Wales
Anticoagulation in patients undergoing cardioversion at Hampshire Hospitals NHS Foundation Trust
A study of the implementation of romiplostim & eltrombopag in the NHS in England
Evaluation of the body fluid mode on the XE-5000 for counting leukocytes in bronchoalveolar lavage fluid
Bone marrow trephines ≥12 mm adequate when reported in an integrated diagnostic service
The impact of formal chemotherapy training on haematology registrars
Formalising palliative care education augments clinical skills in haematology trainees
A retrospective audit of send-away haematological malignancy diagnostic tests at a District General Hospital highlights the importance of local guidelines to reduce inappropriate testing
Idiopathic systemic capillary leak syndrome treated successfully with maintenance intravenous immunoglobulin
Management of the ‘Choose and Book’ system for polycythaemia/thrombocytosis by the MPN specialist nurse
A single centre review of the use and outcomes of cranial imaging for in-patients with haematological malignancies
The development and review of performance assessment scoring in blood films for parasites external quality assessment
Second line treatment for immune thrombocytopenia (ITP): a review of patients with immune thrombocytopenia in Basildon Hospital
Carbapenem resistant gram negative organisms as emerging pathogens in neutropenic fever
Integration of haemato-oncology and palliative care services and staff perceptions to referral
A survey of genetic haemochromatosis testing pattern in a tertiary centre
Autologous 111In- labelled platelet scan as a predictor of splenectomy outcome in ITP
An email advice service for non-urgent general practitioners’ haematological queries
Hickman line infection rates, causative organisms and impacts on recurrence - a retrospective analysis at the James Cook University Hospital, Middlesbrough
Management of anaemia in a resource limited setting: an observational study of current practice at Queen Elizabeth Central Hospital, Malawi
Quality improvement project: pre-printed drug labels to improve patient safety on a large haematology unit
A virtual learning environment: an innovative high quality tool to provide laboratory training in haematology
New conclusions in scintigraphy: results of sickle cell disease bone involvements
A regional review of maternal thrombocytopenia
Does trans-cutaneous electrical nerve stimulation (TENS) alleviate the pain experienced during bone marrow sampling in addition to standard techniques? A randomised, double-blinded, controlled trial
Managing paroxysmal nocturnal haemoglobinuria (PNH) in pregnancy in the eculizumab era: a case series
Annual British Society for Haematology confidential survey of bone marrow examination associated adverse events 2013
Halving the number of tests to differentiate iron deficiency anaemia from anaemia of chronic disease
Blood cultures and antibiotics sensitivities in haematology patients
An audit of the initial assessment of aplastic anaemia in a single region
A review of central line-associated bloodstream infections in adult haematology patients in a BCSH level 3 district general hospital
The use of thrombopoeitin (TPO) in the clinical diagnosis of immune thrombocytopenia (ITP)
The effects of Triton-X on haematological assays when used as an inactivator for Ebola virus
A case report may lead to addendum to BSH treatment guideline of acquired VWD
The importance of determining other possible inherited explanations for an elevated ferritin other than type 1 hereditary haemochromatosis: when not to venesect your patient
Refractory atypical Rosai-Dorfman disease (RDD) successfully treated according to a Langerhans cell histiocytosis regimen
Venous thromboembolism (VTE) in hospitalised non-surgical cancer patients and its burden on healthcare in an Asian tertiary hospital
Recurrence of VTE over 4 years: local outcome data to determine and compare location of VTE events for hospital or community acquired VTE
Direct oral anti-coagulants for prevention of stroke and systemic embolism in non-valvular atrial fibrillation - Barts Health experience across two sites
Systemic therapy in acquired haemophilia A: a single institute experience
A double-centre retrospective study into rates of postpartum haemorrhage in women on low molecular weight heparin
Acute nurse-led VTE service reduces admission and facilitates NOAC use for VTE
Accuracy of published FVIII/FIX:C assay result times: implications for pharmacokinetic (PK) guided dose predictions: a UK-PK study pilot
Audit of the effect of the introduction of a guideline for the management of superficial vein thrombosis to a nurse-led DVT clinic
Evaluation of pathology quality assurance review recommendations: Data from a UK NEQAS for Blood Coagulation (UK NEQAS BC) questionnaire
Quality and predictors of anticoagulation with Warfarin in atrial fibrillation patients
Investigation to determine the miRNA profile and their functional properties in erythrocytes
Characteristics of patients with factor IX Leyden from a single centre
Measuring safety outcomes after lower limb orthopaedic surgery: are we improving outcomes?
Review of factor XI deficiency: bleeding phenotype and clnical considerations
Trends in diagnosis and mortality from thrombotic thrombocytopenic purpura in England from 2003 to 2013: are we improving outcomes?
Higher Warfarin dosage of above 10 mg leads to lower time in therapeutic range
A case of heparin-induced thrombocytopenia with thrombosis and cross-reacting antibodies to fondaparinux successfully treated with rivaroxaban
Cancer-associated VTE occurring over 1 year in a small district general hospital
Patients with suspected TTP should be acutely managed in a critical care setting
A study of DOAC awareness indicating inadequate recognition with potential for patient harm
Inferior vena cava agenesis - an unusual cause of unprovoked deep vein thrombosis presenting with characteristic features in young patients
New UKHCDO von Willebrand disease guidelines allow re-classification of a large proportion of adult patients and can result in de-diagnosis of patients without haemorrhagic consequences
Thrombopoietin-receptor agonists in immune thrombocytopaenic purpura: our experience at East Kent Hospitals University NHS Foundation Trust
The effect on standard haemostasis assays in patients receiving apixaban
Effects of Apixaban on routine tests of haemostasis as determined with a full range of reagents: results of a UK NEQAS exercise
Low incidence of VTE but with high early mortality in patients with diffuse large B cell lymphoma (DLBCL) receiving rituximab based chemotherapy
Outcomes of Warfarin use in haemodialysis
Short and long term neurological complications of thrombotic thrombocytopenic purpura (TTP)
Demographic characteristics, prevalent comorbidities and treatment patterns: initial analysis from the United Kingdom Immune Thrombocytopenia (UK ITP) Registry
A case of idiopathic acquired factor Xlll deficiency
Using modified Wells rule and age adjusted D dimer in diagnosis of deep vein thrombosis
The need for pre-test probability scoring in suspected deep venous thrombosis (DVT) in pregnancy identified by survey of practitioners; should the LEFt clinical prediction rule be adopted?
Rare platelet disorder treatment and antibody screening: a North London network audit
Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIVassociated Burkitt Lymphoma is safe when used with concurrent cART
Burden of venothromboembolism and thromboprophylaxis at East Kent Hospitals NHS Foundation Trust in patients with myeloma treated with immunomodulatory drugs (IMid) containing regimens between 2009 and 2014: a retrospective study
Prospective audit of rivaroxaban as thromboprophylaxis and treatment during myeloma therapy with immunomodulatory drugs (IMiDs) at East Kent Hospitals NHS Foundation Trust
The frequency and characteristics of thrombotic events in adults and children treated for acute lymphoblastic leukaemia at a single centre
MGUS Tracker - an alternative way of monitoring MGUS outside the haematology clinic
Health-related quality of life impact of idelalisib in patients with relapsed chronic lymphocytic leukemia (CLL): phase 3 results
Obinutuzumab (GA101) in combination with CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) or bendamustine for the first-line treatment of follicular non-Hodgkin lymphoma: final results from the maintenance phase of the phase Ib GAUDI study
Patient-reported outcomes data from a phase 2 study of idelalisib in patients with refractory indolent B-cell non-hodgkin lymphoma (iNHL)
An audit of compliance with the NICE guideline for the use of lenalidomide therapy in patients with myeloma
Significant gender differences in the number and distribution of T cells in patients with mantle cell lymphoma
Lenalidomide in relapsed/refractory aggressive lymphoma
Use of PET-CT for patients with multiple myeloma at St Bartholomew's Hospital (SBH)
Skeletal survey reported by experienced radiologist remains adequate as first-line radiological test for the majority of newlydiagnosed patients with multiple myeloma
Rare, fulminant presentations of anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma - a case series
Age but not BMI affects overall survival in Hodgkin lymphoma
Outcomes from a single centre for patients with multiply relapsed myeloma treated with bendamustine containing regimens
Estimation of the clinical benefit of idelalisib in double-refractory follicular lymphoma: Inference from uncontrolled study results
Update on a phase 2 study of idelalisib in combination with rituximab in treatment-naïve patients ≥65 years with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
Outcome of transplantation in mantle cell lymphoma at University Hospitals Leicester - a single centre experience
Follow up in de novo diffuse large B cell lymphoma patients treated with RCHOP: a new approach
Audit of central nervous system (CNS) prophylaxis in patient with diffuse large B-cell lymphoma (DLBCL)
Single centre experience of a Bruton's tyrosine kinase (BTK) specific inhibitor (ONO-4059) in relapsed mantle cell lymphoma (MCL)
Single-agent ibrutinib for the treatment of mantle cell lymphoma (MCL): evaluating the link between durable response and quality of life (QoL) in the SPARK study
Life-threatening bowel perforation while on thalidomide-based triplet regimen for multiple myeloma: a retrospective case series
The North-West Amyloidosis Centre: Hub and spoke model of care for patients with amyloidosis in the United Kingdom (UK)
Current use of nephelometric quantification of serum free light chains (FLCs) in the management of plasma cell dyscrasias, and the potential benefits of point-of-care testing
A new trust protocol can reduce inappropriate requests for serum free light chain analysis
ABVD and escalated BEACOPP for young advanced stage Hodgkin lymphoma
Incidence of complex karyotype in CLL patients at King's College Hospital tertiary referral practice: implications for novel therapies
Off trial use of brentuximab vedotin in Hodgkin lymphoma - a regional experience
How does myeloma present in the 21st century?
Single centre experience of R-mini CHOP for the treatment of elderly patients with diffuse large B-cell lymphoma
Safety and efficacy of bendamustine use in patients with chronic lymphocytic leukaemia
Risk factors associated with the development of infusion-related reactions (IRRs) in patients with chronic lymphocytic leukaemia (CLL) treated with anti-CD20 monoclonal antibodies (mAbs) in combination with chlorambucil: analysis of the prospective, randomised phase III CLL11 study dataset
Ibrutinib in chronic lymphocytic leukaemia: experience from the East of the network
Pattern of cytokine release in patients with chronic lymphocytic leukaemia treated with obinutuzumab and possible relationship with development of infusion related reactions (IRR)
How accurate is the systemic anti-cancer therapy chemotherapy dataset for patients with lymphoproliferative disorders?
Retrospective observational study of patients with relapsed/refractory myeloma treated with pomalidomide - the UK Experience
Screening for and management of steroidinduced hyperglycaemia (SIH) in haematology outpatients
Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone (Pix), etoposide, and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-Hodgkin lymphomas (aNHL)
Identifying MYC dysregulation in diffuse large B-cell lymphoma (DLBCL): correlation between immunohistochemistry (IHC) and fluorescencein-situ hybridisation (FISH)
Implementing a remote surveillance programme for lymphoma patients
Outcome for patients with relapsed/refractory lymphoma treated with gemcitabine and oxaliplatin with or without rituximab
A survey of skeletal survey examinations in a tertiary centre
Utility of skeletal survey in the assessment of symptomatic multiple myeloma in the current era
Survival rates in elderly patients with diffuse large B-cell lymphoma over the last 20 years
Real world efficacy of pomalidomide for relapsed myeloma - a multicentre restrospective study
Evolution of the management of multiple myeloma in a district general hospital setting; a retrospective review of renal impairment and survival
Comparison of ibrutinib and idelalisib + rituximab trials in patients with previously treated chronic lymphocytic leukaemia
Factors influencing treatment initiation in patients with chronic lymphocytic leukaemia (CLL): evaluation of clinical characteristics in >27,500 newly-diagnosed patients
Pharmacokinetics and safety of elotuzumab in combination with lenalidomide and dexamethasone in patients with multiple myeloma and various levels of renal function: updated results of a phase 1b study
Haematologic and immunologic function and patient-reported outcomes for the phase 3 RESONATETM study of ibrutinib versus ofatumumab in relapsed/refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma
Pattern of use of anticoagulation and/or antiplatelet agents in patients with chronic lymphocytic leukaemia (CLL) treated with single-agent ibrutinib
Results from the phase 2 RESONATETM-17 Trial: Efficacy and safety of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic leukaemia with 17p deletion
Does CD5 have an effect on the expression of ROR1 in chronic lymphocytic leukaemia?
Combination therapy with Falcarinol on human lymphoid leukaemia cell lines and increase the expression of cytochrome C, Bax and SMAC/ Diablo
Antiproliferative and induction of apoptosis by pomegranate's anthocyanidins (delphinidin, cyanidin and pelargonidin) on lymphoid and myelopid leukaemia cell lines
Subversion of PKCα signalling in B cell progenitors results in an upregulation of PKCβII expression and leukaemogenesis
Next-generation sequencing in chronic lymphocytic leukaemia using Ion Torrent PGM shows evidence of chemotherapy-induced mutagenesis and a snowballing effect due to loss of p53/ATM-mediated DNA repair
Chronic lymphocytic leukaemia (CLL) with t (1;6)(p35.3;p25.2) involving IRF4 and RCC1 and its effect on the regulation of IRF4 expression; a disease subtype associated with a poor outcome
Advancing leukaemia and lymphoma therapy by ex-vivo compound screening
T follicular helper cells in the follicular lymphoma microenvironment and germinal centres have a close spatial relationship with proliferating B cells, show features of synapse formation and are associated with expression of activation induced cytidine deaminase
Optimisation of RNA extraction and RT-qPCR for the quantification of AID in archived FFPE biopsy samples: only two sections of 4 μm tissue are required
Bruton's tyrosine kinase inhibition regulates chronic lymphocytic leukaemia cell migration by modulation of cell surface adhesion marker profile
A novel B-cell receptor (BCR) internalisation assay reveals patients with adverse CLL have hyper-functional BCRs
Delay in referral and diagnosis of chronic haeamatological malignancies in a tertiary hospital in Tanzania
Primary imatinib resistance in chronic myeloid leukaemia patients: a critical analysis of BCR-ABL kinase domain mutations and clinical outcomes in a developing country
Monitoring in the community - establishment of a service for patients with chronic myeloid leukaemia who have achieved a major molecular response
Efficacy of azacitidine in the treatment of acute myeloid leukaemia (blasts >30%) in comparison to MDS
Investigating differences in serum and plasma values in galactomannan testing, signal loss and sources of false positivity
Local experience with ruxolitinib in primary and secondary myelofibrosis: an analysis of 10 patients treated with ruxolitinib in the Hull and East Yorkshire NHS Trust
The risk of acute incapacitation at relapse of acute myeloid leukaemia (AML): mode of presentation and severity of symptoms
Frequency and Management of Breakthrough Fungal Infections in Patients with AML/ALL on antifungal prophylaxis
The effect on outcome of dose capping for obese patients undergoing induction chemotherapy for acute myeloid leukaemia
Single centre experience in the use of pegylated interferon alpha for myeloproliferative neoplasms
Azacitidine: Duration of treatment used in routine clinical practice in patients with myelodysplastic syndromes (MDS) in England
Azacitidine use in North West London: an update
Feasibility of recruitment of hydroxyurearesistant or intolerant ET and PV patients into the MAJIC study
Baseline quality of life and symptom burden characteristics of patients intolerant to hydroxyurea: Preliminary results from the MAJIC Trial
Nilotinib as first line tyrosine kinase inhibitor treatment for newly diagnosed chronic myeloid leukaemia patients: a preliminary review of the clinical presentation and outcomes in a developing country
Convenient care for patients: A real world evaluation to describe the NHS impact of administering velcade® (bortezomib) in a home setting for patients with multiple myeloma
Factors affecting response to erythropoietin in low risk MDS patients
Alternate day lenalidamide as a well-tolerated and cost-effective treatment in multiple myeloma
Utility of integrated diagnostic reporting (IDR) in patients with myeloid malignancies
Ruxolitinib withdrawal syndrome
CALR mutations in myeloproliferative neoplasm related splanchnic vein thrombosis
Challenges in ETV6-ABL1 positive CML treatment and monitoring: a case report
How well are patients with myeloproliferative neoplasms assessed for cardiovascular risk: an audit report
Single centre experience of treating three cases of relapsed/refractory BRAF mutated Erdheim Chester disease (ECD) with vemurafenib
Prevalence and clinical impact of IDH1 and IDH2 mutations among cytogenetically normal Egyptian acute myeloid leukaemia patients
Prognostic impact of CD25, and CD123 expression in acute myeloid leukaemia patients
Stimulation of TLR-4 promotes increased proliferation and resistance to NK-induced apoptosis in acute myeloid leukaemia
MUC1 suppresses MiR34a expression leading to an expansion of myeloid-derived suppressor cells (MDSCs) in acute myeloid leukaemia
Perturbation of JAK2-dependent transcriptional and inflammatory gene expression in polycythaemia vera
Using induced pluripotent stem cells as a replacement for in-vivo models to screen novel therapies which target leukaemic stem cells in CML
The molecular and therapeutic relevance of SF3B1 in myelodysplastic syndrome
Modulation of mutated cohesin complex gene expression in acute myeloid leukaemia cell lines
The role of Notch signalling in a blast crisis chronic myeloid leukaemia phenotype
Telomere length analysis provides unique insights into the pathogenesis of MDS and AML and is associated with a worse overall survival in MDS but not AML
Dual PI3K/mTOR inhibition in combination with inhibition of autophagy to improve treatment response for BCR-ABL independent mechanisms of TKI-resistance in CML
Expression of the transcription factors FOG1, FLI-1 and GATA1 in the peripheral blood of essential thrombocythaemia patients
Seroprevalence of undiagnosed transfusion transmissible infections (HIV, hepatitis B and C and syphilis) in donated blood in National Blood Banks, Khartoum, Sudan
Real time audit of transfusion practice is very different from standard audits
Audit into HLA-typing and HLA-sensitisation in patients with inherited platelet disorders attending the West of Scotland Haemophilia Comprehensive Care Centre
Blood transfusion and the intensive care unit
The impact of maternal allo-antibodies on the clinical outcomes of foetuses/neonates at Barts Health NHS Trust
Red cell depletion in automated red cell exchange: a safe and effective method of exchange transfusion whilst reducing blood usage
Incidence of Rh and Kell blood group antigens among blood donors in Qatar
Consent to long-term multiple blood transfusions for patients admitted to the haematology ward: a complete audit cycle and quality improvement project
The impact of poor haematology sampling and labelling on the decision to transfuse patients
Traditional audit methods to assess blood component use: limitations of time and efficiency
Successful renal transplantation in Jehovah's Witnesses -shouldn't we apply our approach to blood refusers to all patients, to reduce risks associated with blood transfusions?
Contribution of the British Bone Marrow Registry (BBMR) to the UK transplant activity in 2007 and investigation of final donors in this year
The use and outcomes of prothrombin complex concentrate in a district general hospital
High-dose chemotherapy and autologous stem cell transplantation is feasible and effective for patients with human immunodeficiency virus and primary central nervous system lymphoma
Engraftment post melphalan autologous stem cell transplant (ASCT) for multiple myeloma (MM): Granulocyte colony stimulating factor (G-CSF) initiation correlates with neutrophil recovery independent of CD34 dose: a study from 3 United Kingdom Centres
Full term pregnancy in patient with sickle cell disease and a renal transplant
An audit showing the effect of modern myeloma treatments on service delivery: How will day units cope with the increase in demand in the future?
The need for independent prescribers on a busy haematology day unit: an audit of the quantity and type of drugs prescribed on an ad-hoc basis
High recruitment into interventional clinical trials is possible in the setting of a district general trust (DGT): results of a short prospective audit
Auditing a new myeloma clinic
An audit showing how we improved waiting times in the Cardiff Lymphoma Clinic
Clinical trials: A survey of recruitment figures, screening failures and interventions used to increase recruitment over 4 year period in a teaching hospital
Reduction of depression and anxiety scores following psychotherapy in haematooncological patients
Effects of the 2013 MHRA update on codeine use: a retrospective study of admissions to hospital with an acute vaso-occlusive pain crisis in children with sickle cell disease
Audit of low molecular weight heparin dosing and anti-Xa monitoring in paediatric patients in the University Hospitals of Leicester
Prospective audit of the use of healthcare passports for patients with sickle cell disease
Radiologic evaluation of osteonecrosis of femoralhead in homozygous sickle cell disease
Iron deficiency anaemia during pregnancy: the treatment approaches and outcomes
A review of the services available to support people with sickle cell disease in South London
Use of analgesia in sickle cell crisis at Volta Regional Hospital, Ho, Ghana
Line colonisation in automated red cell exchange transfusion for sickle cell anaemia
Audit into the management of acute painful sickle crisis in the first 2 hours of admission and the use of patient-controlled analgesia
A cross sectional survey to explore GP involvement in the management of sickle cell disease in primary care in City and Hackney
Mortality in adult with sickle cell disease. Sixteen years’ experience in a single centre in London
An investigation of barriers affecting the use of hydroxycarbamide in the adult sickle cell disease population
Haemoglobinopathy screening pathways and attitudes to opportunistic screening for haemoglobinopathies
Exploring the psychosocial implications of living and coping with sickle cell crisis: an interpretative phenomenological analysis
Safety and efficacy of elective automated red cell exchange transfusion programmes for patients with sickle cell disease at a single centre